Early indications suggest that 2025 will be a year of significant advancement for the healthcare industry in Orange County as demonstrated by the substantive increase in the market capitalization of ...

A fresh report on the U.S. life sciences sector is back from the lab with an inconclusive prognosis despite an improved investment environment in 2024. The niche industry struggled throughout 2024 in ...

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the commencement of an underwritten public offering of $100.0 ...

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized underwritten public offering of ...

Tarsus Pharmaceuticals announced a $100 million underwritten public offering of its common stock, with a 30-day underwriter option for additional shares. Tarsus Pharmaceuticals, Inc. has announced ...

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the commencement of ...

IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the commencement of an underwritten public ...